Tülay Tunçer Peker

Tülay Tunçer Peker

Auto-generated profile, based on publicly available information

Tülay Tunçer Peker

Department of Anesthesiology and Reanimation - Critical Care, University of Health Sciences, Gülhane Education and Research Hospital, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Turkish Journal of Intensive Care
Verified
Journal Article
Closed access
BKBehiye Deniz Kosovali
Behiye Deniz Kosovali
GKGÜL MERAL KOCABEYOĞLU
GÜL MERAL KOCABEYOĞLU
NMNevzat Mehmet Mutlu
Nevzat Mehmet Mutlu
TPTülay Tuncer Peker
Tülay Tuncer Peker
ÖSÖzlem Balkız Soyal
Özlem Balkız Soyal
ITIşıl Ozkocak Turan
Işıl Ozkocak Turan
Amaç: Pandeminin ilk dört aylık döneminde koronavirüs hastalığı-2019 (COVİD-19) şüphesiyle, COVİD-19 YBÜ’lerine kabul edilen hastalar tanılarına ve dönemlere göre karşılaştırıldı. Gereç ve Yöntem: Tek merkezde aynı algoritma ile COVİD-19 YBÜ’ye kabul edilen 1,430 hasta verisi retrospektif olarak kaydedildi. Hastalar polimeraz zincirleme reaksiyonu sonucu ile radyolojik ve klinik bulgulara göre COVİD-19 ve non-COVİD-19 hastalar olarak sınıflandırıldılar. Ayrıca COVİD-19 hastaları mortalite ve sağkalım açısından da karşılaştırıldı. Bunun yanında, pandeminin başlangıcı ve normalleşme döneminde COVİD-19 YBÜ’lerine kabul edilen hastaların verileri değerlendirildi. Bulgular: Çalışmaya alınan 1,430 hastanın 630’u COVİD-19, 800’ü non-COVİD-19 gruptaydı. Yaş ortalamalarında anlamlı bir farklılık bulunurken, cinsiyetler arasında bir farklılık yoktu (p=0,001, p=0,262). COVİD-19 ölen grubun yaş ortalaması yaşayan gruptan daha yüksekti (p

30 August 2017 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
STSeckin Tuncer
Seckin Tuncer
TPTülay Tuncer Peker
Tülay Tuncer Peker
IBİlKsen Burat
İlKsen Burat
EKErhan Kiziltan
Erhan Kiziltan
BIBarkin İlHan
Barkin İlHan
NDNizamettin Dalkiliç
Nizamettin Dalkiliç
In this study, effects of the long-acting amide-type local anesthetic levobupivacaine on axonal conduction and excitability parameters of the rat sciatic nerve were thoroughly examined both in vitro and in vivo. In order to deduce its effects on isolated nerve conduction, compound nerve action potential (CNAP) recordings were performed using the suction method over sciatic nerves of Wistar rats before and after administration of 0.05 % (1.7 mmol L−1) levobupivacaine. Levobupivacaine caused complete CNAP area and amplitude depression by blocking conduction in a time-dependent manner. To assess the influence of levobupivacaine on in vivo excitability properties, threshold-tracking (TT) protocols were performed at sciatic nerves of rats injected with perineural 0.05 % (1.7 mmol L−1) levobupivacaine or vehicle alone. Charge-duration TT results revealed that levobupivacaine increases the rheobase and decreases the strength-duration time constant, suggesting interference of the anesthetic with the opening of Na+ channels. Twenty and 40 % threshold electrotonus curves were found for both groups to follow the same paths, suggesting no significant effect of levobupivacaine on K+ channels for either the fastest or relatively slow conducting fibers. Current-threshold relationship results revealed no significant effect on axonal rectifying channels. However, according to the results of the recovery cycle protocol yielding the pattern of excitability changes following the impulse, potential deviation was found in the recovery characteristics of Na+ channels from the absolute refractory period. Consequently, conduction blockage caused by levobupivacaine may not be due to the passive (capacitive) properties of axon or the conductance of potassium channels but to the decrease in sodium channel conductance.

26 March 2022 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
PDF file
BKBehiye Deniz Kosovali
Behiye Deniz Kosovali
EÇEsra Yurduseven Çivgin
Esra Yurduseven Çivgin
EOERDEM OZKAN
ERDEM OZKAN
TPTülay Tunçer Peker
Tülay Tunçer Peker
MMMehmet Mutlu
Mehmet Mutlu
Aim: Chest computed tomography (CT) plays an important role in the diagnosis of coronavirus infection disease 2019 (COVID-19) in patients with negative polymerase chain reaction (PCR) test but with clinical findings. The aim of this study; to determine whether the disease can predict clinical severity and/or mortality with CO-RADS and/or CTSS in intensive care COVID-19 patients. Materials and Methods: In the study retrospectively, COVID-19 intensive care patients with PCR positive and chest CT between 23 March - 31 December 2020 were included. CTs were evaluated by two independent radiologists without providing the clinical information of the patients. CO-RADS and CTSS were calculated for each CT, and pathological features were recorded. Demographic, clinical characteristics and mortality rates of the patients were recorded. Patients were divided into three groups [mild (nasal/mask oxygen), severe (noninvasive mechanichal ventilator (NIMV) or high flow nasal oxygen (HFO)), critically severe (invasive mechanichal ventilation (IMV))] according to the clinical severity of COVID-19. Mortality and clinical severity markers were determined by logistic regression analysis. Results: Four hundered seventy three patients were included in the study. Patients were divided into three groups according to clinical severity, mild (34.7%), severe (11.8%), and critically severe (53.5%). The mean CTSS of all patients was 19.58 and the rate of patients in the CO-RADS 5 group was 50.7%. The mortality rate was 41.2%. APACHE II score and CTSS were preductors of clinical severity; age, female gender and CO-RADS were found as mortality preductors. The CO-RADS cut-off value predicting mortality was 5. Ground glass appearance was the most common pathological finding with a rate of 84.4%. Receiver operating characteristic (ROC) curves were drawn for mortality markers CO-RADS and APACHE II, and the area under the curve (AUC) values were 0.580 and 0.881, respectively. AUC was found to be 0.697 in the ROC curve drawn for CTSS, which is a clinical indicator of severity. The mortality cut-off value was found to be 16.5 with 77% sensitivity and 79% specificity for the APACHE II score (LR:3.7). The clinical severity cut-off value was found to be 18.5, with 61% sensitivity and 66% specificity for the CTSS. Conclusion: CO-RADS can be used to predict mortality and CTSS can be used to predict clinical severity which are radiological-based scoring systems.

27 October 2026 in Challenge Journal of Perioperative Medicine
Verified
Journal Article
Open access
PDF file
NMNevzat Mehmet Mutlu
Nevzat Mehmet Mutlu
MSMurat Sakallı
Murat Sakallı
ÖSÖzlem Balkız Soyal
Özlem Balkız Soyal
TPTülay Tunçer Peker
Tülay Tunçer Peker
DEDeniz Erdem
Deniz Erdem
NGNermin Göğüş
Nermin Göğüş
Objective: This historical cohort, originally collected as a prospective, randomized study was re-analyzed to compare propofol–remifentanil–based intravenous anesthesia (P‑RIA) and sevoflurane‑based balanced anesthesia (BA) regarding ST‑segment–defined myocardial ischemia and hemodynamic stability in elderly ASA II–III patients with cardiovascular comorbidities undergoing monopolar transurethral resection of the prostate (TURP). As troponin measurements were unavailable, myocardial injury after non‑cardiac surgery (MINS) was considered only as a conceptual framework rather than a predefined endpoint.Methods: Sixty‑six patients scheduled for elective monopolar TURP (n = 33 per group) were randomized in a single‑center, outcome‑assessor‑blinded design to receive P‑RIA or BA. Continuous ST‑segment monitoring (leads DII, V5, aVL) was performed from 15 minutes before induction to 15 minutes postoperatively. ECGs were read by a blinded cardiologist, and hemodynamics, electrolytes, and CK‑MB/CK were recorded serially.Results: Baseline demographic and surgical characteristics, as well as overall ischemia incidence and duration, were similar between groups. Blood pressure and heart rate were lower and more stable with P‑RIA. At 15 minutes postoperatively, ischemia was less frequent in the P‑RIA group than in the BA group (15.2% vs 36.4%; p = 0.045), an exploratory finding. CK‑MB levels, CK‑MB/CK ratios, electrolyte values, and postoperative complications did not differ significantly.Conclusion: In this elderly, comorbid TURP cohort, P‑RIA was associated with a more stable hemodynamic profile and a transiently lower early postoperative ischemia rate, without reducing total perioperative ischemic burden or CK‑MB–based myocardial injury. The data are hypothesis‑generating and require confirmation in larger troponin‑based MINS studies.

27 May 2024
Verified
Book
Open access
PDF file
HDHayriye Cankar Dal
Hayriye Cankar Dal
EYEsra YAKIŞIK
Esra YAKIŞIK
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
ITIşıl Ozkocak Turan
Işıl Ozkocak Turan
MYMehmet Eren Yuksel
Mehmet Eren Yuksel
IMİbRahim Mungan
İbRahim Mungan
Akut Böbrek Hasarı Tanımı ve Patofizyolojisi Hayriye CANKAR DAL Akut Böbrek Hasarı Biyobelirteçleri Esra YAKIŞIK ÇAKIR Akut Böbrek Hasarında Renal Koruma Ayşe Müge KARCIOĞLU Işıl ÖZKOÇAK TURAN Akut Böbrek Hasarının Yönetimi ve Renal Replasman Tedavisi Dışındaki Tedavi Yöntemleri Mehmet Eren YÜKSEL Ahmet Gökhan AKDAĞ Sürekli Renal Replasman Tedavisi Tarihçesi Derya GÖKÇINAR Fizyolojik Prensipler ve Terminoloji Büşra TEZCAN Cihazın Yapısı ve Bileşenleri Sema TURAN Çilem BAYINDIR DİCLE Sürekli Renal Replasman Tedavisinde Kullanılan Membran ve Filtreler Tülay TUNÇER PEKER Sevil BALTACI ÖZEN Sürekli Renal Replasman Tedavisinde Kullanılan Tampon Solüsyonlar Belgin AKAN Kurulum Behiye Deniz KOSOVALI Sürekli Renal Replasman Tedavisinde Gösterge ve Alarmlar Serdar YAMANYAR Sürekli Renal Replasman Tedavisinde Vasküler Erişim Yolları Berkay KÜÇÜK Belgin AKAN Sürekli Renal Replasman Tedavisi Endikasyonları ve Zamanlama Mete ERDEMİR Sercan YILMAZ Levent YAMANEL Tedavi Modalitesi Seçimi Dilek ÖZTÜRK KAZANCI Müçteba CAN Dozun Belirlenmesi ve Reçeteleme Hasan DİRİK Demet BÖLÜKBAŞI Rejyonel Sitrat Antikoagülasyonu Mehmet Eren YÜKSEL Seval İZDEŞ Sitrat Dışı Antikoagülasyon Baha Burak KONAK Seval İZDEŞ Hasta Monitörizasyonu ve Sonlandırma Kararı Mahmut YILMAZ Gürhan TAŞKIN Sürekli Renal Replasman Tedavisinin Komplikasyonları Şerife GÖKBULUT BEKTAŞ Ahmet Bilal KANDEMİR Sepsis ve SRRT Dilek ÖZTÜRK KAZANCI Sema SARI Sürekli Renal Replasman Tedavisinde Sıvı Yönetimi Cihangir DOĞU Beslenme ve Sürekli Renal Replasman Tedavisi Deniz ERDEM ECMO Uygulanan Hastada SRRT Sema TURAN İbrahim MUNGAN İlaç Uygulamaları ve SRRT Tülay TUNÇER PEKER Sürekli Renal Replasman Tedavisinin Ekstrarenal Endikasyonları Baha Burak KONAK Seval İZDEŞ Çoklu Organ Destek Tedavisi Derya GÖKÇINAR

27 May 2024
Verified
Book Chapter
Closed access
TPTülay Tunçer Peker
Tülay Tunçer Peker